Vertex Pharmaceuticals to Buy Alpine Immune Sciences for $4.9 Billion
Vertex Pharmaceuticals (NASD:VRTX) bought Alpine Immune for $4.9 billion for an all cash offer to get access to Alpines kidney disease treatments.The offer is a significant upgrade to current market value of Alpine Immune Sciences as its a 67% premium...